Image

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

I-SPY Trial: Testing new treatments for breast cancer before surgery.

Recruiting
18 years and older
All
Phase 2

The **I-SPY Trial** is a research study designed to find the best ways to treat different types of breast cancer using new drugs before surgery. Doctors will look at how well these drugs work with standard chemotherapy. The study uses **MRI** (magnetic resonance imaging) pictures and samples of tissue and blood to see how the cancer responds to the treatment. This helps doctors predict which treatments might be successful for specific types of breast cancer.

To join the study, you must be at least 18 years old and have breast cancer that hasn't been treated with chemotherapy or radiation. You can’t have metal implants that would interfere with an MRI. You must also be willing to have a biopsy, which is when a small piece of the tumor is taken to study. You need to sign a consent form agreeing to be part of the study.

  • The study involves **new drugs and standard treatment** to see which works best for different cancers.
  • You need to be **at least 18 years old** and agree to have tests and biopsies.
  • Participants must be **able to have an MRI** and not have certain health issues or metal implants.
Study details
    Breast Neoplasms
    Breast Cancer
    Breast Tumors
    Angiosarcoma
    TNBC - Triple-Negative Breast Cancer
    HER2-positive Breast Cancer
    HER2-negative Breast Cancer
    Hormone Receptor Positive Tumor
    Hormone Receptor Negative Tumor
    Early-stage Breast Cancer
    Locally Advanced Breast Cancer

NCT01042379

QuantumLeap Healthcare Collaborative

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.